Sign In
Buy CODX
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc. (NASDAQ:CODX) has announced that its Logix Smart SARS-CoV-2 DS (Direct Saliva) test has obtained regulatory authorization to be sold as an in vitro diagnostic (IVD) for the diagno
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test
10:30am, Friday, 18'th Jun 2021
SALT LAKE CITY, June 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Wall Street takes a turn for the worse as investors eye Fed
12:20pm, Tuesday, 15'th Jun 2021
12:15pm: The Dow was down 161 points, 0.5%, at 34,233 at midday. The Nasdaq lost 85 points, 0.6%, to 14,088, and the S&P 500 ticked down 11 points, 0.3%, to 4,244.
Co-Diagnostics says it will be presenting virtually at two conferences this week
10:49am, Tuesday, 15'th Jun 2021
Co-Diagnostics, Inc. (NASDAQ:CODX) said it will be presenting virtually this week at the 28th International Biodetection Technologies Conference, as well as hosting a virtual booth at the 65th Annual
Co-Diagnostics says it will be presenting virtually at two conferences virtually this week
09:33am, Tuesday, 15'th Jun 2021
Co-Diagnostics, Inc. (NASDAQ:CODX) said it will be presenting virtually this week at the 28th International Biodetection Technologies Conference, as well as hosting a virtual booth at the 65th Annual
Co-Diagnostics: No One-Hit Wonder
04:22pm, Friday, 04'th Jun 2021
Vaccine hesitancy and new coronavirus variants are a threat to herd immunity. The alternative solution to vaccination for re-opening the economy is mass testing.
5 Stocks To Watch For May 14, 2021
04:43am, Friday, 14'th May 2021
Some of the stocks that may grab investor focus today are: Walt Disney Co (NYSE: DIS) reported upbeat earnings for its second quarter, while sales missed expectations. Disney+ ended the second quarter
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2021 Results - Earnings Call Transcript
10:35pm, Thursday, 13'th May 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2021 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Beats Q1 Earnings and Revenue Estimates
07:41pm, Thursday, 13'th May 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 30.00% and 2.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Co-Diagnostics Q1 Earnings
05:21pm, Thursday, 13'th May 2021
Shares of Co-Diagnostics (NASDAQ:CODX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 620.00% year over year to $0.26, which
Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test
04:59pm, Thursday, 13'th May 2021
Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Smart COVID-19 Test. For the quarter ended March 31, th
CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: Should You Buy?
03:46pm, Thursday, 06'th May 2021
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast
09:30am, Tuesday, 04'th May 2021
SALT LAKE CITY, May 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, an
